USPTO serial 86584777
EKOS RESOLVE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KHOURI, SANI PHILIPPE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with EKOS RESOLVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan A. Hyman
JONATHAN A. HYMAN Knobbe Martens Olson & Bear Llp2040 Main St Fl 14Irvine, CA 92614-8214UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medicinal preparations and substances for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; Pharmaceutical and medicinal preparations and substances, namely, lysing solutions and reagents, and hemolytic lysing solutions and reagents; chemical reagents for medical therapeutic purposes; chemico-pharmaceutical preparations for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs | ACTIVE | — |
| 010 | Surgical apparatus and instruments; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; Medical apparatus and instruments for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and software sold as a unit therewith; drug delivery apparatus and instruments, namely, ultrasonic medical apparatus; Drug delivery apparatus and instruments, namely, ultrasonic medical apparatus and software sold as a unit therewith; Drug delivery systems; surgical and medical apparatus and instruments for use in treatment of the circulatory system; Medical apparatus and instruments for use in the prevention and treatment of the circulatory system issues and conditions, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; medical devices which use ultrasound to enhance drug delivery and medically activate drugs; catheters for delivery of drugs and fluids and controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus and controllers and power units therefor; catheters; parts and fittings for all the aforesaid goods | ACTIVE | — |
| 041 | Education services, namely, developing, arranging and conducting educational conferences and programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; training in the use and operation of medical devices, medical ultrasound apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma and distribution of course material in connection therewith; providing computer, electronic and on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; advisory services in the fields of medical education; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, and Intracranial Hemorrhages, cerebral hemorrages, and hematoma; electronic on-line databases featuring information about medical education in the field of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EKOS Corporation
- Other trademarks owned by EKOS Corporation
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Similar marks named EKOS RESOLVE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 15, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 15, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 27, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 23, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 23, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 23, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 12, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 2, 2016 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Feb 22, 2016 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 3, 2016 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Feb 3, 2016 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 15, 2016 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Nov 30, 2015 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 3, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 3, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 14, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 18, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 10, 2015 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jul 15, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 15, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 15, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 8, 2015 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jul 8, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 7, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 19, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jun 11, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Apr 11, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2015 | NWAP | NEW APPLICATION ENTERED | — |